These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2825331)

  • 1. [Remote (2-3 years) results in patients with pulmonary tuberculosis treated in operational conditions in combination with sinerdol-EH].
    Păunescu E; Mihăilescu P; Fonea M; Ciocan A; Serban G; Eliescu A; Serban S; Grigorescu C; Tiţei I; Popescu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(2):137-44. PubMed ID: 2825331
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary results of a short-course antituberculosis regimen including Sinerdol-EH and applied under operational conditions.
    Păunescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):149-55. PubMed ID: 2999952
    [No Abstract]   [Full Text] [Related]  

  • 3. The advantages of the antituberculosis regimens which include Sinerdol-EH, a new tuberculostatic of rifampicin-type.
    Păunescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):33-42. PubMed ID: 6312533
    [No Abstract]   [Full Text] [Related]  

  • 4. [Short-course chemotherapy for tuberculosis in Chile. Operational considerations].
    Valenzuela P; Valenzuela MT
    Rev Med Chil; 1984 Mar; 112(3):287-9. PubMed ID: 6473970
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves rifapentine for the treatment of pulmonary tuberculosis.... Food and Drug Administration.
    Roehr B
    J Int Assoc Physicians AIDS Care; 1998 Aug; 4(8):19-25. PubMed ID: 11365728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C; Lecocguic Y; Touaty E; Bussi S; Pariente R
    Rev Fr Mal Respir; 1982; 10(6):391-9. PubMed ID: 6819611
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifapentine for the treatment of pulmonary tuberculosis.
    Munsiff SS; Kambili C; Ahuja SD
    Clin Infect Dis; 2006 Dec; 43(11):1468-75. PubMed ID: 17083024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another step on the path to better TB therapies.
    Vernon A; Burman W; Horsburgh CR
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):1-2. PubMed ID: 11931394
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination therapy with butomelide and rifampicin in experimental tuberculosis in albino mice].
    Pershin GN; Zykova TN; Kutchak SN
    Probl Tuberk; 1977 Jan; (1):64-9. PubMed ID: 834763
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
    Rabukhin AE; Gol'dshteĭn VD; Khodakevich LIa
    Probl Tuberk; 1974; (7):14-8. PubMed ID: 4409887
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Tarasova EF; Sagalovich VIa
    Probl Tuberk; 1974; (12):26-30. PubMed ID: 4445131
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of tuberculosis under routine conditions in Czechoslovakia.
    Danková D
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):182-6. PubMed ID: 2999962
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of treatment with rifampicin in 39 patients hospitalized in our service during 1970-1971-1972].
    Maalej M; Chabbou A; Zbiba M; El Gharbi B; Halfon S; El Gharbi T; Cheniti M; El Mekki L; Djen Ayah F; Chebbi ML; Jeguirim M; Ben Salah M
    Tunis Med; 1974; 52(6):313-6. PubMed ID: 4619937
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical course and effectiveness of treatment of destructive pulmonary tuberculosis in adolescents].
    Firsova VA; Nadyrshina RSh; Melikova VM
    Probl Tuberk; 1986; (5):14-7. PubMed ID: 3737587
    [No Abstract]   [Full Text] [Related]  

  • 19. Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease.
    Mitchison DA
    Soc Appl Bacteriol Symp Ser; 1996; 25():72S-80S. PubMed ID: 8972122
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.